As of 2026-09-27, the EV/EBITDA ratio of Moderna Inc (MRNA) is -27.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 77,818.59 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,797.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 14.0x | 12.5x |
| Forward P/E multiples | 11.1x - 15.2x | 13.3x |
| Fair Price | (76.75) - (95.93) | (88.17) |
| Upside | -138.6% - -148.2% | -144.3% |
| Date | EV/EBITDA |
| 2026-09-25 | -27.82 |
| 2026-09-24 | -27.25 |
| 2026-09-23 | -25.44 |
| 2026-09-22 | -25.51 |
| 2026-09-21 | -24.14 |
| 2026-09-18 | -21.46 |
| 2026-09-17 | -22.03 |
| 2026-09-16 | -20.27 |
| 2026-09-15 | -20.00 |
| 2026-09-14 | -20.42 |
| 2026-09-11 | -20.03 |
| 2026-09-10 | -18.99 |
| 2026-09-09 | -18.85 |
| 2026-09-08 | -19.52 |
| 2026-09-04 | -20.26 |
| 2026-09-03 | -20.73 |
| 2026-09-02 | -21.00 |
| 2026-09-01 | -21.49 |
| 2026-08-31 | -19.52 |
| 2026-08-28 | -19.18 |
| 2026-08-27 | -19.86 |
| 2026-08-26 | -20.84 |
| 2026-08-25 | -22.14 |
| 2026-08-24 | -19.31 |
| 2026-08-21 | -20.20 |
| 2026-08-20 | -18.52 |
| 2026-08-19 | -24.35 |
| 2026-08-18 | -8.54 |
| 2026-08-17 | -8.75 |
| 2026-08-14 | -8.59 |
| 2026-08-13 | -8.64 |
| 2026-08-12 | -8.64 |
| 2026-08-11 | -8.20 |
| 2026-08-10 | -8.09 |
| 2026-08-07 | -8.00 |
| 2026-08-06 | -7.25 |
| 2026-08-05 | -7.59 |
| 2026-08-04 | -7.69 |
| 2026-08-03 | -7.43 |
| 2026-07-31 | -7.39 |
| 2026-07-30 | -7.83 |
| 2026-07-29 | -7.34 |
| 2026-07-28 | -7.53 |
| 2026-07-27 | -7.50 |
| 2026-07-24 | -7.28 |
| 2026-07-23 | -7.70 |
| 2026-07-22 | -7.85 |
| 2026-07-21 | -8.07 |
| 2026-07-20 | -8.05 |
| 2026-07-17 | -8.38 |